31 Mar
2019

Charting China’s changing pharma patent landscape

China’s attempts to strengthen IP protection and harness innovation have accelerated in recent years. With the country emerging as a critical market for the pharmaceuticals industry, it is crucial to take stock of how these reforms affect the unique challenges faced by life sciences innovators

Adam Houldsworth

Life sciences reporter

IAM

[email protected]